- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04490226
Endogenous vs. Exogenous Ketone Bodies
Impact of Endogenous vs. Exogenous Ketone Bodies on Appetite Control and Macronutrient Oxidation
Aim of the study is to compare the origin of ketone bodies: endogenous ketone bodies due to 36 hours fasting or 24 hours of ketogenic diet vs. exogenous ketone bodies as supplements additional to normal diet.
Secondary aim of the study is to validate the new metabolic chambers.
Study Overview
Status
Conditions
Detailed Description
Each study week starts with a 3-day run-in period with controlled diet at home and ends with a test-meal (breakfast) in the lab and following food record over the rest of the day at home.
- week: physical activity level (PAL) 1.3, 3 intervention days in the metabolic chamber: ad libitum energy intake, washout day, isocaloric diet, 36 hours fasting
- week: physical activity level (PAL) 1.3, 2 intervention days in the metabolic chamber: isocaloric diet, 36 hours fasting
- week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber: ad libitum energy intake, 36 hours fasting
- week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber: isocaloric diet, ketogenic diet (isocaloric)
- week: physical activity level (PAL) 1.6, 2 intervention days in the metabolic chamber: isocaloric diet, isocaloric diet + ketone body supplements (isocaloric)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kiel, Germany, 24105
- Institute of Human Nutrition
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy
- BMI 19-29 kg/m2
- low-medium habitual physical activity
- women using hormonal contraceptive
Exclusion Criteria:
- smoking
- chronic illnesses
- food allergies / intolerances
- vegans and vegetarians
- regular high physical activity (exercise >1 hour/d)
- current weight loss diet / weight loss of >5 kg in the last 3 months
- pregnant / lactating women
- persons incapable of giving informed legal consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: fasting, active
36 hours fasting, PAL 1.6
|
24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3. The same intervention is reproduced one week later. |
Experimental: ketogenic diet, active
24 hours of ketogenic diet (liquid meals), PAL 1.6
|
24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3. The same intervention is reproduced one week later. |
Experimental: exogeneous ketone bodies, active
24 hours of ketone body supplements (Beta-Hydroxybutyrate as Ca-Mg-salt) additional to a normal diet (liquid meals), PAL 1.6
|
24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3. The same intervention is reproduced one week later. |
Experimental: fasting, inactive
36 hours fasting, PAL 1.3
|
24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3. The same intervention is reproduced one week later. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
appetite control - ghrelin
Time Frame: 24 hours
|
ghrelin concentration in plasma (24 hour AUC)
|
24 hours
|
appetite control - GLP-1 concentration in plasma
Time Frame: 24 hours
|
Glucose Like Peptide-1 concentration in plasma (24 hour AUC)
|
24 hours
|
appetite control - PYY concentration in plasma
Time Frame: 24 hours
|
Peptide YY concentration in plasma (24 hour AUC)
|
24 hours
|
appetite control - subjective feelings of hunger
Time Frame: 24 hours
|
measured with visual analogue scales (24 hour AUC).
The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.
|
24 hours
|
appetite control - satiety quotient
Time Frame: 30 min
|
satiety quotient of standard test-breakfast after 24 hours of intervention
|
30 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
macronutrient oxidation
Time Frame: 24 hours
|
measured with indirect calorimetry in a metabolic chamber
|
24 hours
|
energy expenditure
Time Frame: 24 hours
|
measured with indirect calorimetry in a metabolic chamber
|
24 hours
|
glycemia - glucose AUC
Time Frame: 24 hours
|
glucose AUC from continuous glucose monitoring data
|
24 hours
|
repeatability of energy expenditure measurements
Time Frame: 24 hours
|
repeated measurement of 24h-energy expenditure in a metabolic chamber on inactive isocaloric and fasting days
|
24 hours
|
ß-Hydroxybutyrate concentration in serum
Time Frame: 24 hours
|
24 hour ß-Hydroxybutyrate concentration in serum (AUC)
|
24 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ABW-2020-VK
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
-
King's College LondonUniversity of ReadingCompletedHealthy | Healthy AgingUnited Kingdom
Clinical Trials on Beta-Hydroxybutyrate as Ca-Mg-salt, active
-
University Hospital, Basel, SwitzerlandCompleted
-
McMaster UniversityMediPharm Labs CorpWithdrawnGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | AgoraphobiaCanada
-
CytokineticsRecruitingObstructive Hypertrophic Cardiomyopathy (oHCM)United States, Netherlands, United Kingdom, France, Spain, China, Israel, Denmark, Italy, Germany, Hungary, Canada
-
Serdinsek TamaraCompletedOveractive Bladder | Overactive Bladder SyndromeSlovenia
-
Defense and Veterans Center for Integrative Pain...CompletedLaparoscopic CholecystectomyUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom
-
FBM Industria Brasileira LtdaAzidus Brasil Scientific Research and Development LtdaUnknown
-
Vastra Gotaland RegionEnrolling by invitationMusculoskeletal Diseases | Neuromuscular Diseases | Centronuclear Myopathy | Nemaline Myopathy | Congenital Myopathy | Myosin Storage MyopathySweden
-
Afyon Kocatepe University HospitalCompleted